<?xml version="1.0" encoding="UTF-8"?>
<ArticalData xmlns="http://www.consortiumpublisher.com">
  <Header>
    <ArticleTitle>International Conference of Pharmaceutical and Medical Sciences</ArticleTitle>
  </Header>
  <ArticleParameters>
    <ArticleReceivingDate>2020-01-01</ArticleReceivingDate>
    <ArticleRevisedDate>2020-01-01</ArticleRevisedDate>
    <ArticleAcceptanceDate>2020-01-01</ArticleAcceptanceDate>
    <ArticlePublishedOn>9/30/2024 11:29:28 AM</ArticlePublishedOn>
    <Journal>Journal of Applied Pharmacy</Journal>
    <Volume>12</Volume>
    <Year>2020</Year>
    <ArticleType>Original research article</ArticleType>
    <FirstPage>84</FirstPage>
    <LastPage>85</LastPage>
    <CollectionYear>2020</CollectionYear>
    <PublisherId>___________________________</PublisherId>
    <ArticleDoi>http://dx.doi.org/10.21065/19204159.12.84</ArticleDoi>
    <Language>English</Language>
  </ArticleParameters>
  <Authors>
    <ArticleAuthors>Bertha Serwa Ayi</ArticleAuthors>
  </Authors>
  <keywords>
    <Articlekeywords>--------------------------------------------------------------------------</Articlekeywords>
  </keywords>
  <Abstract>
    <ArticleAbstract>The SARS-CoV-2 virus is a novel coronavirus that has ravaged the world. Given that there are no established treatments for coronaviruses, it presents a treatment dilemma for scientists. This presentation explores the mechanisms that go into decision making on the best treatment course for this illness with a special focus on the role of Hydroxychloroquine and Zinc.</ArticleAbstract>
  </Abstract>
</ArticalData>